A Randomized Controlled Trial to evaluate the efficacy of Shatavari Taila Matrabasti in the management of Kashtartava with special reference to Primary Dysmenorrhoea.
试验速览
- 阶段
- 2/3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 120
- 试验地点
- 1
- 主要终点
- To evaluate the efficacy of Shatavari Taila Matrabasti in the management of Kashtartava with special reference to Primary Dysmenorrhea on VAS scale
研究概览
简要总结
This study is randomized, parallel group, open labelled, controlled clinical trial to evaluate and compare the efficacy of Shatavari Taila Matrabasti and Tila Taila Matrabasti in Kashtartava with special referance to Primary Dysmenorrhea. Study Population- Adolescent girls of age 18-24 years having symptoms of Kashtartava.120 patients of Kashtartava from OPD, IPD and Casualty of Govt. Ayurved Hospital, Nagpur will be taken. They will be divided into two groups by the random number table method. The trial group will be administered Shatavari Taila Matrabasti 60 ml once a day for 7 days before commencement of menses for 3 consecutive menstrual cycles and the comparison group will be administered Tila Taila Matrabasti 60 ml once a day before commencement of menses for 3 consecutive menstrual cycles. Comparison of the effects on the subjective parameters before and after treatment between two groups will be done. Follow-ups will be done. The results will be analyzed statistically to draw conclusions from the study.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 24.00 Year(s)（—）
- 性别
- Female
入选标准
- •Patients coming with complaint of painful menses.
- •Adolescent girls of age between 18 to 24 years.
- •Patients suffering from Kashtartava for at least 3 consecutive regular menstrual cycles.
- •Patient who agrees to participate and is ready to sign the informed consent form.
排除标准
- •Patients below 18 years and above 24 years.
- •Married women.
- •Patients of Secondary dysmenorrhoea.
- •Patients having congenital anomaly of reproductive tract like hypoplastic uterus.
- •Patients having organic pathology of uterus and adnexa like fibroid uterus, carcinoma of endometrium.
- •Patients with Dysfunctional uterine bleeding, Pelvic Inflammatory diseases, Endometritis.
- •Patients having conditions where surgical intervention should be needed.
- •8.Patients with systemic diseases.
- •9.Patients taking hormonal therapy.
- •10.Patient who is not willing to give informed consent.
结局指标
主要结局
To evaluate the efficacy of Shatavari Taila Matrabasti in the management of Kashtartava with special reference to Primary Dysmenorrhea on VAS scale
时间窗: before treatment (on day 1 and day 5)and after treatment (on day 1 and day 5)
次要结局
- Effect of Shatavari Taila Matrabasti on reduction in intensity & duration of pain present in Kashtartava with special referance to Primary Dysmenorrhea(before treatment (on day 1 & day 5)and after treatment (on day 1 & day 5))
研究者
Dr Preeti Kshitij Jadhav
Government Ayurved College and Hospital , Nagpur